Over the last few years, the number of recombinant pharmaceutical products that have entered the regulatory fray to gain approval for marketing has grown rapidly, and is now in the hundreds. As ...
Like all areas of bioprocessing, downstream purification has its own favored buzzwords—titers, bottlenecks, capacity, and others—meant to evoke a particular response depending on who is speaking or ...
Enveloped viruses have tremendous potential in a number of areas of great interest to biotech and pharma firms including gene therapy and vaccination. These viruses, which are typically produced in ...
Master of Biotechnology program (MBP) student Anita Huang looks back on her six-month internship at UCB in the United Kingdom and what she learned from the experience. In 2019, two students in ...
Sartorius Stedim Biotech partners with cell culture media specialist SAFC Biosciences® to provide world-class fluid management and liquid/powder system solutions Global agreement strengthens ...
Milestone Marks Completion of First Phase of Two-Part Myford Facility Expansion; First Customer Project to Begin in New Downstream Processing Suite in Coming Month TUSTIN, Calif., Jan. 10, 2022 (GLOBE ...
A consortium of companies in the European process industry including biotechnology, renewable resources, chemistry, process engineering, equipment and research organizations launched project PRODIAS ...
(MENAFN- GlobeNewsWire - Nasdaq) The market is poised for growth (12.88% CAGR), driven by high demand for equipment due to capacity expansions, and the adoption of single-use systems, continuous ...
- Belgian Acquisition Means Novasep Offers Full-Range of Biomanufacturing Solutions POMPEY, France, July 6 /PRNewswire/ -- Novasep, a leading producer of active pharmaceutical ingredients (APIs) and ...
PRODIAS (PROcessing Diluted Aqueous Systems) fosters competitiveness of the European process industryAim is to decrease production costs for renewable-based products via increasing the efficiency of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results